You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

HSE hit with €50 million TAS bill

By Mindo - 21st Sep 2017 | 4 views

Between 2012 and 2016, the TAS cost the HSE €45.5 million, including travel expenses, on providing treatment for 3,285 patients. For the first six months of this year, the scheme has cost the HSE €4.5 million for medical treatments and €33,876 for travel expenses.

In 2016, €8.7 million was spent on treatment while €83,525.50 was spent on travel expenses for 661 approved patients under the TAS.

Between January and the end of June 2017, 336 applications were approved by the HSE for the TAS. During this period, 434 visits abroad have been undertaken by approved patients, according to figures released through Freedom of Information legislation.

In the five-and-half-year period from 2012 to mid-2017 a total of 207 applications to avail of the TAS were refused.

The TAS allows consultants based in Ireland to refer a patient that is normally resident in Ireland for treatment in another EU member state or Switzerland, where the treatment in question meets set criteria.

While the HSE would not release detailed information regarding the countries and treatment accessed under the scheme, it did confirm that the most common regions visited were the UK, Germany, Sweden and France.

The most common treatments accessed under the TAS include deep brain stimulation, paediatric organ transplantation, gender reassignment surgery, SAP scans, and bladder exstrophy surgery.

The introduction of the Cross Border Directive (CBD) (in June 2014) has meant some applicants to the TAS are now choosing to access care under the CBD as opposed to TAS, the HSE told <strong><em>MI</em></strong>.

“The usual reason for this is to access the care in the private healthcare sector abroad where they are less likely to be subject to waiting lists.”

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read